Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

NCT04086485 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

56

Enrollment

NIH

Sponsor class

Conditions

Gastroenteropancreatico Tumors
Neuroendocrine Tumors
Neuroendocrine Neoplasms

Interventions

DRUG: Lu-177-DOTATATE
DRUG: Olaparib
DIAGNOSTIC_TEST: Ga dotatate scanning
DIAGNOSTIC_TEST: FDG-PET scanning
DRUG: Amino Acid infusion

Sponsor

National Cancer Institute (NCI)